GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Ending Cash Position

Qingdao Vland Biotech Co (SHSE:603739) Ending Cash Position : ¥262 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Ending Cash Position?

Qingdao Vland Biotech Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥262 Mil.

Qingdao Vland Biotech Co's quarterly Ending Cash Position increased from Mar. 2024 (¥183 Mil) to Jun. 2024 (¥253 Mil) and increased from Jun. 2024 (¥253 Mil) to Sep. 2024 (¥262 Mil).

Qingdao Vland Biotech Co's annual Ending Cash Position declined from Dec. 2021 (¥312 Mil) to Dec. 2022 (¥208 Mil) but then increased from Dec. 2022 (¥208 Mil) to Dec. 2023 (¥222 Mil).

Qingdao Vland Biotech Co Ending Cash Position Historical Data

The historical data trend for Qingdao Vland Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Ending Cash Position Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.99 249.89 311.76 207.69 221.72

Qingdao Vland Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228.36 221.72 182.51 252.87 261.68

Qingdao Vland Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Qingdao Vland Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=207.693+14.028
=222

Qingdao Vland Biotech Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=252.871+8.806
=262

Qingdao Vland Biotech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Vland Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Ending Cash Position
Comparable Companies
SZSE:300147 SZSE:300583 SZSE:301166 SZSE:300878 SZSE:300404 SZSE:000504 SHSE:688137 SHSE:605177 SZSE:000710 SZSE:300238 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Website
http://www.vlandgroup.com
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co Headlines

No Headlines